NO303693B1 - Rent humant korboksyterminalt propeptid av type I prokollagen, antistoff og anvendelse av antistoff fremstilt mot dette, samt analysesett som omfatter antistoffet - Google Patents
Rent humant korboksyterminalt propeptid av type I prokollagen, antistoff og anvendelse av antistoff fremstilt mot dette, samt analysesett som omfatter antistoffet Download PDFInfo
- Publication number
- NO303693B1 NO303693B1 NO912493A NO912493A NO303693B1 NO 303693 B1 NO303693 B1 NO 303693B1 NO 912493 A NO912493 A NO 912493A NO 912493 A NO912493 A NO 912493A NO 303693 B1 NO303693 B1 NO 303693B1
- Authority
- NO
- Norway
- Prior art keywords
- antibody
- procollagen
- propeptide
- type
- carboxy
- Prior art date
Links
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 title claims abstract description 32
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 title claims abstract description 32
- 238000003149 assay kit Methods 0.000 title 1
- 102000001187 Collagen Type III Human genes 0.000 claims abstract description 24
- 108010069502 Collagen Type III Proteins 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims description 22
- 108090000672 Annexin A5 Proteins 0.000 claims description 19
- 238000002372 labelling Methods 0.000 claims description 13
- 238000004458 analytical method Methods 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- 238000004255 ion exchange chromatography Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 239000002523 lectin Substances 0.000 claims description 3
- 206010003445 Ascites Diseases 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000005191 phase separation Methods 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 108010050808 Procollagen Proteins 0.000 description 12
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000012506 Sephacryl® Substances 0.000 description 4
- 238000009739 binding Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108010062580 Concanavalin A Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 102100038803 Somatotropin Human genes 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- NBCQBGBECVUZMK-UHFFFAOYSA-N (4-carboxyphenyl)mercury;hydrate Chemical compound O.OC(=O)C1=CC=C([Hg])C=C1 NBCQBGBECVUZMK-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 102100030152 Complement C1r subcomponent-like protein Human genes 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001622557 Hesperia Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100326463 Homo sapiens C1RL gene Proteins 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010065081 Phosphorylase b Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- ZCYVEMRRCGMTRW-YPZZEJLDSA-N iodine-125 Chemical compound [125I] ZCYVEMRRCGMTRW-YPZZEJLDSA-N 0.000 description 1
- 229940044173 iodine-125 Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960001479 tosylchloramide sodium Drugs 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Detergent Compositions (AREA)
- Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
- Filters For Electric Vacuum Cleaners (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909014220A GB9014220D0 (en) | 1990-06-26 | 1990-06-26 | Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO912493D0 NO912493D0 (no) | 1991-06-25 |
| NO912493L NO912493L (no) | 1991-12-27 |
| NO303693B1 true NO303693B1 (no) | 1998-08-17 |
Family
ID=10678234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO912493A NO303693B1 (no) | 1990-06-26 | 1991-06-25 | Rent humant korboksyterminalt propeptid av type I prokollagen, antistoff og anvendelse av antistoff fremstilt mot dette, samt analysesett som omfatter antistoffet |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5698407A (fi) |
| EP (1) | EP0465104B1 (fi) |
| JP (1) | JP3137676B2 (fi) |
| AT (1) | ATE142646T1 (fi) |
| DE (1) | DE69121990T2 (fi) |
| DK (1) | DK0465104T3 (fi) |
| ES (1) | ES2091292T3 (fi) |
| FI (1) | FI104079B1 (fi) |
| GB (2) | GB9014220D0 (fi) |
| GR (1) | GR3021053T3 (fi) |
| NO (1) | NO303693B1 (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4225038C2 (de) * | 1992-07-29 | 1995-11-30 | Boehringer Mannheim Gmbh | Herstellung und Verwendung von Antikörpern gegen Kollagen |
| CA2152667C (en) * | 1992-12-28 | 2003-02-11 | David J. Baylink | Bone resorption assay |
| CA2167496A1 (en) * | 1993-07-28 | 1995-02-09 | Werner Naser | Immunoassay for the detection of collagen or collagen fragments |
| GB9506050D0 (en) | 1995-03-24 | 1995-05-10 | Osteometer A S | Assaying collagen fragments in body fluids |
| AU3746295A (en) | 1994-10-17 | 1996-05-06 | Osteometer Biotech As | Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen |
| GB9507985D0 (en) * | 1995-04-19 | 1995-06-07 | Orion Yhtymae Oy | Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it |
| PT859838E (pt) | 1995-08-31 | 2003-10-31 | Univ Manchester | Novos procolagenios |
| US6107047A (en) * | 1996-03-21 | 2000-08-22 | Osteometer Biotech A/S | Assaying protein fragments in body fluids |
| GB9617616D0 (en) | 1996-08-22 | 1996-10-02 | Osteometer Biotech As | Assaying protein fragments in body fluids |
| DE69705423T2 (de) | 1996-12-09 | 2002-05-16 | Osteometer Biotech As Herlev | Sandwichtest zum nachweis von kollagenfragmenten |
| ATE258310T1 (de) * | 1997-07-31 | 2004-02-15 | Metra Biosystems Inc | Testverfahren für collagenpeptid |
| US6117646A (en) * | 1997-09-22 | 2000-09-12 | Osteometer Biotech A/S | Assaying protein fragments in body fluids |
| WO2012122334A2 (en) * | 2011-03-08 | 2012-09-13 | The Johns Hopkins University | Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases |
| KR101787485B1 (ko) | 2015-12-30 | 2017-11-15 | 재단법인 의약바이오컨버젼스연구단 | 재조합 picp 단백질 및 이에 특이적으로 결합하는 항체의 제조방법 |
| JP2021151953A (ja) * | 2018-03-30 | 2021-09-30 | 独立行政法人国立高等専門学校機構 | 組換え構造タンパク質の製造方法、組換え構造タンパク質、タンパク質成形体及びタンパク質成形体の製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208865B (en) * | 1987-08-19 | 1991-12-11 | Farmos Group Ltd | Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody. |
| AU3687889A (en) * | 1988-04-29 | 1989-11-24 | Bionovus, Inc. | Improved micro-hplc |
-
1990
- 1990-06-26 GB GB909014220A patent/GB9014220D0/en active Pending
-
1991
- 1991-06-24 FI FI913069A patent/FI104079B1/fi not_active IP Right Cessation
- 1991-06-25 NO NO912493A patent/NO303693B1/no not_active IP Right Cessation
- 1991-06-25 JP JP03153281A patent/JP3137676B2/ja not_active Expired - Lifetime
- 1991-06-26 EP EP91305768A patent/EP0465104B1/en not_active Expired - Lifetime
- 1991-06-26 DE DE69121990T patent/DE69121990T2/de not_active Expired - Lifetime
- 1991-06-26 DK DK91305768.3T patent/DK0465104T3/da active
- 1991-06-26 AT AT91305768T patent/ATE142646T1/de not_active IP Right Cessation
- 1991-06-26 GB GB9113791A patent/GB2245568A/en not_active Withdrawn
- 1991-06-26 ES ES91305768T patent/ES2091292T3/es not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/464,557 patent/US5698407A/en not_active Expired - Lifetime
-
1996
- 1996-09-17 GR GR960402421T patent/GR3021053T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9113791D0 (en) | 1991-08-14 |
| GB9014220D0 (en) | 1990-08-15 |
| NO912493L (no) | 1991-12-27 |
| EP0465104A1 (en) | 1992-01-08 |
| ES2091292T3 (es) | 1996-11-01 |
| DE69121990D1 (de) | 1996-10-17 |
| US5698407A (en) | 1997-12-16 |
| GB2245568A (en) | 1992-01-08 |
| ATE142646T1 (de) | 1996-09-15 |
| FI913069A0 (fi) | 1991-06-24 |
| NO912493D0 (no) | 1991-06-25 |
| JPH04261199A (ja) | 1992-09-17 |
| DE69121990T2 (de) | 1997-01-23 |
| DK0465104T3 (da) | 1996-09-30 |
| FI104079B (fi) | 1999-11-15 |
| FI104079B1 (fi) | 1999-11-15 |
| GR3021053T3 (en) | 1996-12-31 |
| EP0465104B1 (en) | 1996-09-11 |
| JP3137676B2 (ja) | 2001-02-26 |
| FI913069A (fi) | 1991-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0699306B1 (en) | Assay for cardiac troponin i | |
| Edelman et al. | Immunological studies of human γ-globulin: Relation of the precipitin lines of whole γ-globulin to those of the fragments produced by papain | |
| Olins et al. | The antigenic structure of the polypeptide chains of human γ-globulin | |
| EP0465104B1 (en) | Method for the immunological determination of the carboxyterminal propeptide of type I procollagen | |
| Stauber et al. | The γ‐aminobutyric‐acid/benzodiazepine‐receptor protein from rat brain: Large‐scale purification and preparation of antibodies | |
| EP0304292B1 (en) | Antibody to propeptide of procollagen type III, and assay method using it | |
| Askonas et al. | ENZYMATICALLY PRODUCED SUBUNITS OF PROTEINS FORMED BY PLASMA CELLS IN MICE: II. ß2A-Myeloma Protein and Bence Jones Protein | |
| CA2174559C (en) | Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it | |
| Deutsch | Relationships of two light chain immunoglobulins isolated from the same human source (low molecular weight immunoglobins) | |
| US4863850A (en) | Method for diagnosis of rheumatoid arthritis | |
| US6008325A (en) | Antibody to aminoterminal propeptide of type 1 procollagen | |
| US4297274A (en) | Protein from red blood cells and process for isolating it | |
| JPH076982B2 (ja) | 抗 体 | |
| US5702904A (en) | Immunoassay for identifying alcoholics and monitoring alcohol consumption | |
| EP0450095B1 (en) | Method of assaying d-vanillylmandelic acid, and reagent and kit therefor | |
| Ikebuchi et al. | An immunological study of a Pb-thionein like protein in rat liver | |
| Szerlip et al. | Relationship of the aldosterone-induced protein, GP70, to the conductive Na+ channel. | |
| JPS62502304A (ja) | 哺乳動物中の早期妊娠因子の検出法並びに早期妊娠因子の精製法及びその単クロ−ン抗体の生成法 | |
| JPS61227596A (ja) | 抗リン酸化チロシンモノクロ−ナル抗体およびそれを産生するハイブリド−マ | |
| POULIK et al. | Production of Monoclonal Antibodies to Dog Post-Gamma Globulin | |
| Delkeskamp et al. | Physicochemical and Immunological Basis of Immunoglobulin Heterogeneity | |
| JPS60243027A (ja) | 抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |